WisdomTree Insights

The AI revolution is reshaping our world, and our strategies are evolving to keep pace. Christopher Gannatti analyzes our WisdomTree Artificial Intelligence & Innovation and U.S. Quality Growth Funds and provides insights into market dynamics and the influence of major AI players like Nvidia and the Magnificent 7.
Read the article
Late 2023 was a period of high hopes for interest rate cuts from the U.S. Federal Reserve. Christopher Gannatti discusses the resulting boom in SaaS stocks and their subsequent decline in the first half of 2024. 
Read the article
Just as earnings season ends, it begins once again. In his new weekly blog series, “Navigating the Earnings Season,” Samuel Rines discusses the upcoming earnings season and the importance of company outlooks for the U.S. and global economies.
Read the article
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In this second part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the journey to the mRNA vaccine.
Read the article
Lately, a hot topic in the investment space has been the timing of when the UST curve could “un”invert. Kevin Flanagan outlines the dynamics behind yield curve movements, including the timing and factors that could cause the yield curve to move out of negative territory.
Read the article

Marine Le Pen’s National Rally (RN) led the first round of the French parliamentary elections, signaling potential gridlock in parliament or a power-sharing scenario with President Macron. Chris Gannatti explains how this political uncertainty, along with France’s fiscal challenges, has caused market disruptions and highlights the importance of focusing on global businesses that are less impacted by local political issues.

Read the article